Peer-reviewedCC BY-NCJournal for immunotherapy of cancer
Cell-delivered CD3×CD19 T-cell engager by STAb-T19 cells mediates leukemia clearance with limited systemic exposure.
6 affiliations
- 1CNIO-HMRIB Cancer Immunotherapy Clinical Reserach Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain [email protected] [email protected].
- 2STAb Therapeutics, Madrid, Spain.
- 3CNIO-HMRIB Cancer Immunotherapy Clinical Reserach Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
- 4Department of Advanced Therapy Drug Development, Instituto de Salud Carlos III, Madrid, Spain.
- 5Cancer Immunotherapy Research Group, Hospital del Mar Research Institute Barcelona (HMRIB), Barcelona, Spain.
- 6Banc de Sang i Teixits (BST), Barcelona, Spain.
Related
- Brain Gadolinium Biodistribution, Clearance, and Retention Following High-Dose Contrast-Agent Exposure in Mice: A Multimodal Study
- LEDGF/p75 Mediates Chemoresistance in Leukemia in a Context Dependent Manner
- The CD112-TIGIT/PVRIG Axis Mediates NK Cell Evasion inDecitabine-Treated Acute Myeloid Leukemia Cells
- Oncogenic signalling and host immunocompetency govern senescent cell clearance and systemic inflammation in a mouse model of oncogene-induced senescence
- Systemic Mastocytosis With Associated Acute Myeloid Leukemia Identified After Induction Therapy: A Case Report and Literature Review
BibTeX
@article{sanzortega2026celldelivered,
title = {{Cell-delivered CD3×CD19 T-cell engager by STAb-T19 cells mediates leukemia clearance with limited systemic exposure.}},
author = {Laura Sanz-Ortega and Elena Barba-Sarasúa and Ivana Zagorac and Antonio Tapia-Galisteo and Lucía Rivas-Gómez and Noelia López and Belén Blanco and Carolina Pola and Luis Alvarez-Vallina},
journal = {Journal for immunotherapy of cancer},
year = {2026},
month = oct,
doi = {10.1136/jitc-2026-015573},
url = {https://europepmc.org/article/MED/42849917},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Cell-delivered CD3×CD19 T-cell engager by STAb-T19 cells mediates leukemia clearance with limited systemic exposure.
AU - Laura Sanz-Ortega
AU - Elena Barba-Sarasúa
AU - Ivana Zagorac
AU - Antonio Tapia-Galisteo
AU - Lucía Rivas-Gómez
AU - Noelia López
AU - Belén Blanco
AU - Carolina Pola
AU - Luis Alvarez-Vallina
PY - 2026
DA - 2026/10/08
JO - Journal for immunotherapy of cancer
DO - 10.1136/jitc-2026-015573
UR - https://europepmc.org/article/MED/42849917
SN - 2051-1426
ER -